These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 29746174)

  • 21. Uraemic syndrome of chronic kidney disease: altered remote sensing and signalling.
    Nigam SK; Bush KT
    Nat Rev Nephrol; 2019 May; 15(5):301-316. PubMed ID: 30728454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Structure and Mechanism of Drug Transporters.
    Roberts AG
    Methods Mol Biol; 2021; 2342():193-234. PubMed ID: 34272696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluorescence-based methods for studying activity and drug-drug interactions of hepatic solute carrier and ATP binding cassette proteins involved in ADME-Tox.
    Özvegy-Laczka C; Ungvári O; Bakos É
    Biochem Pharmacol; 2023 Mar; 209():115448. PubMed ID: 36758706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The SLC22 Transporter Family: A Paradigm for the Impact of Drug Transporters on Metabolic Pathways, Signaling, and Disease.
    Nigam SK
    Annu Rev Pharmacol Toxicol; 2018 Jan; 58():663-687. PubMed ID: 29309257
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Induction of phase I, II and III drug metabolism/transport by xenobiotics.
    Xu C; Li CY; Kong AN
    Arch Pharm Res; 2005 Mar; 28(3):249-68. PubMed ID: 15832810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circadian regulation of transporter expression and implications for drug disposition.
    Pácha J; Balounová K; Soták M
    Expert Opin Drug Metab Toxicol; 2021 Apr; 17(4):425-439. PubMed ID: 33353445
    [No Abstract]   [Full Text] [Related]  

  • 27. Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: An intra-subject analysis.
    Fritz A; Busch D; Lapczuk J; Ostrowski M; Drozdzik M; Oswald S
    Basic Clin Pharmacol Toxicol; 2019 Mar; 124(3):245-255. PubMed ID: 30253071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of chronic kidney disease and uremia on hepatic drug metabolism and transport.
    Yeung CK; Shen DD; Thummel KE; Himmelfarb J
    Kidney Int; 2014 Mar; 85(3):522-8. PubMed ID: 24132209
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intestinal efflux transporters and drug absorption.
    Murakami T; Takano M
    Expert Opin Drug Metab Toxicol; 2008 Jul; 4(7):923-39. PubMed ID: 18624680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diurnal expression of ABC and SLC transporters in jejunum is modulated by adrenalectomy.
    Vagnerová K; Ergang P; Soták M; Balounová K; Kvapilová P; Vodička M; Pácha J
    Comp Biochem Physiol C Toxicol Pharmacol; 2019 Dec; 226():108607. PubMed ID: 31422161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic and/or non-genetic causes for inter-individual and inter-cellular variability in transporter protein expression: implications for understanding drug efficacy and toxicity.
    Koo SH; Lo YL; Yee JY; Lee EJ
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1821-37. PubMed ID: 26489003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ontogeny of Hepatic Transporters and Drug-Metabolizing Enzymes in Humans and in Nonclinical Species.
    van Groen BD; Nicolaï J; Kuik AC; Van Cruchten S; van Peer E; Smits A; Schmidt S; de Wildt SN; Allegaert K; De Schaepdrijver L; Annaert P; Badée J
    Pharmacol Rev; 2021 Apr; 73(2):597-678. PubMed ID: 33608409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells.
    Dolberg AM; Reichl S
    Eur J Pharm Sci; 2018 Oct; 123():277-294. PubMed ID: 30041030
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug Transporters in Xenobiotic Disposition and Pharmacokinetic Prediction.
    Mao Q; Lai Y; Wang J
    Drug Metab Dispos; 2018 May; 46(5):561-566. PubMed ID: 29636376
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of drug-metabolizing enzymes by local and systemic liver injuries.
    Guo Y; Hu B; Xie Y; Billiar TR; Sperry JL; Huang M; Xie W
    Expert Opin Drug Metab Toxicol; 2016; 12(3):245-51. PubMed ID: 26751558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transporter-Mediated Drug-Drug Interactions and Their Significance.
    Liu X
    Adv Exp Med Biol; 2019; 1141():241-291. PubMed ID: 31571167
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dysregulation of Mucosal Membrane Transporters and Drug-Metabolizing Enzymes in Ulcerative Colitis.
    Erdmann P; Bruckmueller H; Martin P; Busch D; Haenisch S; Müller J; Wiechowska-Kozlowska A; Partecke LI; Heidecke CD; Cascorbi I; Drozdzik M; Oswald S
    J Pharm Sci; 2019 Feb; 108(2):1035-1046. PubMed ID: 30267783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of ABCG2 and other urate transporters in uric acid homeostasis in chronic kidney disease: potential role of remote sensing and signaling.
    Bhatnagar V; Richard EL; Wu W; Nievergelt CM; Lipkowitz MS; Jeff J; Maihofer AX; Nigam SK
    Clin Kidney J; 2016 Jun; 9(3):444-53. PubMed ID: 27274832
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Xenobiotic Transporters in the Kidney: Function and Role in Toxicity.
    Shen H; Scialis RJ; Lehman-McKeeman L
    Semin Nephrol; 2019 Mar; 39(2):159-175. PubMed ID: 30827339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute kidney injury, agranulocytosis, drug-induced liver injury, and posterior reversible encephalopathy syndrome caused by high-dose methotrexate-possible role of low activity ABC and SLC drug transporters.
    Bielen L; Kralj I; Ćurčić E; Vodanović M; Boban A; Božina N
    Eur J Clin Pharmacol; 2018 Sep; 74(9):1191-1192. PubMed ID: 29789870
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.